Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 180 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1791 ? Advanced colorectal cancer 5 Chemotherapy
La Paz Spain 11/2005
Treatment Details: Patients: This Phase II study involved 94 patients with untreated advanced colorectal cancer. 58 patients had colon cancer and 36 patinets had rectal cancer. Metastatic sites included lun
 
1792 ? advanced colorectal cancer 5 Chemotherapy
La Paz Spain 11/2005
Treatment Details: Patients: This Phase II study involved 94 patients with untreated advanced colorectal cancer. Metastatic sites included lung, liver, and "abdominopelvis mass". 58 patients had colon cancer
 
1793 ? Stage II and III breast cancer 4 Chemotherapy
University Hospitals of Cleveland United States 12/2005
Treatment Details: Patients: This Phase II study involved 39 women with inoperable or large operable metastatic breast cancer. The median age was 47 years. Treatment: The treatment consisted of two chemoth
 
1794 ? Stage II or III breast cancer 4 Biologic therapy
Chemotherapy
Centre GF Leclerc France 12/2005
Treatment Details: Patients: This Phase II study involved 33 women with HER2-over-expressing stage II or III breast cancer. The patients wished to conserve their affected breasts. The median age was 45. T
 
1795 ? advanced breast cancer 4 Chemotherapy
Azienda Ospedaliera Careggi Italy 1/2006
Treatment Details: Patients: This study involved 31 women with advanced breast cancer. All patients had received chemotherapy before the study. The median age was 61 years. Treatment: The treatment consis
 
1796 ? Metastatic colorectal cancer 4 Biologic therapy
Chemotherapy
Cancer Therapy and Research Center United States 12/2005
Treatment Details: Patients: This Phase I study involved 20 patients with metastatic colorectal cancer. Treatment: The treatment consisted of one biologic agent (oblimersen, which is an antisense oligonucle
 
1797 ? Hormone-refractory prostate cancer 4 Chemotherapy
Sammons Cancer Center United States 2/2005
Treatment Details: Patients: This Phase II study involved 42 men with hormone-refractory metastatic prostate cancer. Metastatic sites include bone and viscera. The median age was 73 years. Most patients had
 
1798 ? Hormone-refractory prostate cancer 4 Biologic therapy
Weill Medical College of Cornell University United States 7/2005
Treatment Details: Patients: This Phase I study involved 35 men with hormone-refractory protstate cancer. The median age was 69 years. Treatment: The treatment consisted of one biological agent: J591, an i
 
1799 ? Locally advanced resectable rectal cancer 3 Chemotherapy
Radiation
C.R.O. National Cancer Institute Italy 11/2005
Treatment Details: Patients: This Phase II study involved 53 patients with locally advanced, resectable, rectal cancer. Thirty-nine patients were men, fourteen were women, and median age was 63 years. Tre
 
1800 ? Advanced rectal cancer 4 Chemotherapy
Radiation
Centre Antoine-Lacassagne France 12/2005
Treatment Details: Patients: This Phase I study involved 43 patients with locally advanced or metastatic rectal cancer. Thirty-four patients were men, nine were women, and the median age was 59 years. Trea
 
Page 180 of 187  | Previous Page  | Next Page